INST 0817: Compassionate Use of Mifepristone.
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2018
At a glance
- Drugs Mifepristone (Primary)
- Indications Adrenocortical carcinoma; Breast cancer; Central serous chorioretinopathy; Colon cancer; Cushing syndrome; Endometrial cancer; Meningioma; Ovarian cancer
- Focus Therapeutic Use
- 26 Aug 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 18 Dec 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
- 22 Oct 2012 Planned end date changed from 1 Nov 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.